Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 2.28 USD -3.39% Market Closed
Market Cap: 104.8m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one KRMD stock under the Base Case scenario is 2.62 USD. Compared to the current market price of 2.28 USD, Repro Med Systems Inc is Undervalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KRMD Relative Value
Base Case
2.62 USD
Undervaluation 13%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.1
P/S
P/S
Price to Sales
3.1
vs History
98
vs Industry
31
Median 3Y
4.1
Median 5Y
5.7
Industry
2.2
Forward
2.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-14.9
Median 5Y
-19.4
Industry
21.9
Forward
-22.7
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-30
Median 5Y
-27.3
Industry
13.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-22
Median 5Y
-22
Industry
19.2
More Details
6.2
P/B
P/B
Price to Book Value
6.2
vs History
25
vs Industry
9
Median 3Y
5.4
Median 5Y
5.4
Industry
2.1
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
98
vs Industry
31
Median 3Y
3.6
Median 5Y
5
Industry
2.3
Forward
2.4
More Details
4.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.5
vs History
98
vs Industry
39
Median 3Y
6.5
Median 5Y
8.3
Industry
4.8
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
6
Median 3Y
-13.9
Median 5Y
-12.8
Industry
11.7
Forward
-171.8
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
5
Median 3Y
-13.1
Median 5Y
-12.1
Industry
15.9
Forward
-18.3
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-27
Median 5Y
-23.2
Industry
13.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-20.7
Median 5Y
-19.6
Industry
16.8
More Details
6
EV/IC
EV/IC
Enterprise Value to IC
6
vs History
69
vs Industry
10
Median 3Y
6.3
Median 5Y
7.3
Industry
1.8
More Details

Multiples Across Competitors

KRMD Competitors Multiples
Repro Med Systems Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Repro Med Systems Inc
NASDAQ:KRMD
104.8m USD 3.1 -17.3 -17.2 -14.8
US
Abbott Laboratories
NYSE:ABT
215.5B USD 5.1 16.1 21.6 31.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
160.8B USD 19.3 69.3 53.4 64.7
US
Boston Scientific Corp
NYSE:BSX
132.2B USD 7.9 71.3 32.8 46.2
US
Stryker Corp
NYSE:SYK
131.9B USD 5.8 44.1 22.9 27.7
IE
Medtronic PLC
NYSE:MDT
106.4B USD 3.2 25 13.4 18.9
US
Becton Dickinson and Co
NYSE:BDX
60.1B USD 2.9 34.4 14.6 26.3
DE
Siemens Healthineers AG
XETRA:SHL
47.4B EUR 2.1 24.2 14.1 20.1
US
Edwards Lifesciences Corp
NYSE:EW
40.8B USD 7.5 9.8 22.9 25.3
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
258.6B CNY 7 20.9 18.1 18.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
32.1B USD 8.2 36.2 25.8 28.7

See Also

Summary
KRMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
KRMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KRMD stock valuation using valuation multiples.
Wall Street Estimates
KRMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KRMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 244,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.